The Penta investment group has decided to further expand its Dr. Max operations outside of the traditional markets of the Czech Republic, Slovakia and Poland. Leonardo Ferrandino (*1970) will be responsible for the management of the entire Dr. Max Group, who has been appointed to the newly created position of Holding CEO. This experience manager arrives at the Penta investment group after 12-years at Admenta Italia, which is part of the Celesio Group.
After several roles in the finance department in Italy and Germany, at Admenta he served as Vice President and CFO responsible for, among other matters, the Finance, IT, and M&A divisions. As of 2009 he headed up the Consumer Solutions retail division and afterward the Pharmacy Solutions division as well.
In 2012, Leonardo became a member of Celesio‘s Group Executive Committee and in 2014 he was involved in developing the business in Italy and Slovenia, as well as leading the Celesio Group Sales and Marketing activities. He also had direct responsibility for the development of the EPN (European Pharmacy Network).
“Dr. Max is one of Penta‘s most successful projects, whose strategy is to consolidate other European market. Leonardo has proven his abilities in the management of pharmacy retail in a number of countries. We believe that his arrival will accelerate both the Group’s expansion as well as its qualitative shift.“ Václav Jirků, Investment Director
Leonardo Ferrandino is married and has two children.
On its current markets, Dr. Max’s pharmacy network consists of 928 pharmacies (Czech Republic- 370, Slovakia - 220, Poland - 338). Poland is seen by Penta as the primary market offering room for further expansion, but Dr. Max’s entry onto other European markets by the end of this year is likely. Penta started building this network in 2004. Today, Dr. Max has 6,232 employees and finished 2015 with sales of EUR 1,050 million.